Abstract
Leucine-rich repeat kinase 2 (LRRK2) is a large multidomain protein with both a Ras of complex (ROC) domain and a kinase domain (KD) and, therefore, exhibits both GTPase and kinase activities. Human genetics studies have linked LRRK2 as a major genetic contributor to familial and sporadic Parkinson's disease (PD), a neurodegenerative movement disorder that inflicts millions worldwide. The C-terminal region of LRRK2 is a Trp-Asp-40 (WD40) domain with poorly defined biological functions but has been implicated in microtubule interaction. Here, we present the crystal structure of the WD40 domain of human LRRK2 at 2.6-Å resolution, which reveals a seven-bladed WD40 fold. The structure displays a dimeric assembly in the crystal, which we further confirm by measurements in solution. We find that structure-based and PD-associated disease mutations in the WD40 domain including the common G2385R polymorphism mainly compromise dimer formation. Assessment of full-length LRRK2 kinase activity by measuring phosphorylation of Rab10, a member of the family of Rab GTPases known to be important kinase substrates of LRRK2, shows enhancement of kinase activity by several dimerization-defective mutants including G2385R, although dimerization impairment does not always result in kinase activation. Furthermore, mapping of phylogenetically conserved residues onto the WD40 domain structure reveals surface patches that may be important for additional functions of LRRK2. Collectively, our analyses provide insights for understanding the structures and functions of LRRK2 and suggest the potential utility of LRRK2 kinase inhibitors in treating PD patients with WD40 domain mutations.
Highlights
| | | leucine-rich repeat kinase 2 (LRRK2) WD40 crystal structure Parkinson’s disease domain-swapped dimeric architecture [9]
We found that the WD40 domain forms dynamic dimers in solution, and both structure-based mutations and Parkinson’s disease (PD)-associated disease variants in the WD40 domain mainly impair its dimerization
Our structure provides a template for elucidating the biological function of the WD40 domain and for understanding how mutations of the domain may affect the function of LRRK2
Summary
| | | LRRK2 WD40 crystal structure Parkinson’s disease domain-swapped dimeric architecture [9]. Crystal structure of a ROC-COR construct of Roco, a prokaryotic homolog of LRRK2, revealed a COR domain mediated dimer [15], and full-length Roco undergoes dynamic monomer-dimer transition during GTP turnover [16]. LRRK2 regulates neurite growth and neurons that express PD-associated LRRK2 mutations show a progressive reduction in neurite length and branching [5, 7]. These neurons display phosphotau–positive inclusions and undergo apoptosis [5, 7]. Because of the association of LRRK2 to PD, the structure of the WD40 domain dimer of human LRRK2 presented here will help elucidate the pathogenesis of certain WD40 mutations and provide structure-based template for potential therapeutic interventions
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have